{"id":2944,"date":"2024-04-17T09:16:36","date_gmt":"2024-04-17T09:16:36","guid":{"rendered":"https:\/\/avaeh.org\/web_nueva_2021\/?p=2944"},"modified":"2024-04-17T09:16:37","modified_gmt":"2024-04-17T09:16:37","slug":"webinar-fepaeh-prilenia-y-aprobacion-de-la-ema","status":"publish","type":"post","link":"https:\/\/avaeh.org\/web_nueva_2021\/2024\/04\/17\/webinar-fepaeh-prilenia-y-aprobacion-de-la-ema\/","title":{"rendered":"Webinar FEPAEH  Prilenia y aprobaci\u00f3n de la EMA"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Ayer, 16 de abril, FEPAEH consigui\u00f3 registrar casi 150 inscripciones al webinar informativo en espa\u00f1ol Prilenia solicita la aprobaci\u00f3n de la Agencia Europea del Medicamento para la Pridopidina \u00bfQu\u00e9 significa esto para los pacientes?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El Dr. Andr\u00e9s Cruz Herranz, director de Desarrollo Cl\u00ednico de Prilenia Therapeutics, y el Dr. Jose Luis Lopez-Send\u00f3n, neur\u00f3logo del Hospital Ram\u00f3n y Cajal, resolvieron las dudas de aquellas personas que participaban desde pa\u00edses como Espa\u00f1a, <a><\/a>Colombia, M\u00e9xico, Ecuador o Argentina, entre otras. Gracias a ambos por apoyar siempre a nuestra comunidad Huntington.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El webinar fue grabado y pronto lo difundiremos en nuestras redes sociales. Agradecer a la European Huntington Association que nos cediera la plataforma online en la que pudimos llegar a tantas diferentes partes del mundo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00a1Hasta pronto!<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"593\" src=\"https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2024\/04\/prilenia-espanol-webinar-1024x593.jpg\" alt=\"\" class=\"wp-image-2945\" srcset=\"https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2024\/04\/prilenia-espanol-webinar-1024x593.jpg 1024w, https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2024\/04\/prilenia-espanol-webinar-300x174.jpg 300w, https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2024\/04\/prilenia-espanol-webinar-768x445.jpg 768w, https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2024\/04\/prilenia-espanol-webinar.jpg 1051w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Ayer, 16 de abril, FEPAEH consigui\u00f3 registrar casi 150 inscripciones al webinar informativo en espa\u00f1ol Prilenia solicita la aprobaci\u00f3n de la Agencia Europea del Medicamento para la Pridopidina \u00bfQu\u00e9 significa esto para los pacientes? El Dr. Andr\u00e9s Cruz Herranz, director de Desarrollo Cl\u00ednico de Prilenia Therapeutics, y el Dr. Jose [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2945,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7,6,4,9,597,596,5,58,536,261,180,8],"class_list":["post-2944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria","tag-asociacion-valenciana-de-enfermedad-de-huntington","tag-avaeh","tag-enfermedad-de-huntington","tag-enfermedades-raras","tag-federacion-espanola-de-personas-afectadas-por-la-enfermedad-de-huntington","tag-fepaeh","tag-huntingtons-disease","tag-neurodegenerativa","tag-pridopidina-huntington","tag-pridopidine","tag-prilenia","tag-rare-diseases"],"_links":{"self":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/comments?post=2944"}],"version-history":[{"count":1,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2944\/revisions"}],"predecessor-version":[{"id":2946,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2944\/revisions\/2946"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media\/2945"}],"wp:attachment":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media?parent=2944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/categories?post=2944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/tags?post=2944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}